{"text": ["Health", "Care", "Sector", "Update", "for", "09/10/2018:", "MYOK,", "ACAD,", "MRK,", "FOLD,", "LLY"], "created_at": "2018-09-10 20:23:15"}
{"text": ["Health", "Care", "Sector", "Update", "for", "09/10/2018:", "MYOK,", "ACAD,", "MRK,", "FOLD,", "LLY"], "created_at": "2018-09-10 20:23:15"}
{"text": ["Eli", "Lilly", "Initiates", "New", "Trial", "for", "Taltz", "in", "Plaque", "Psoriasis"], "created_at": "2018-09-10 18:45:06"}
{"text": ["Health", "Care", "Sector", "Update", "for", "09/10/2018:", "ACAD,MRK,FOLD"], "created_at": "2018-09-10 17:23:06"}
{"text": ["Health", "Care", "Sector", "Update", "for", "09/10/2018:", "ACAD,MRK,FOLD"], "created_at": "2018-09-10 17:23:06"}
{"text": ["Glaxo's", "Nucala", "Suffers", "Regulatory", "Setback,", "Gets", "CRL", "for", "COPD"], "created_at": "2018-09-10 16:47:18"}
{"text": ["Glaxo's", "Nucala", "Suffers", "Regulatory", "Setback,", "Gets", "CRL", "for", "COPD"], "created_at": "2018-09-10 16:47:18"}
{"text": ["Lilly", "to", "Showcase", "New", "Data", "at", "the", "27th", "European", "Academy", "of", "Dermatology", "and", "Venereology", "(EADV)", "Congress,", "Furthering", "Innovation", "for", "Patients", "with", "Complex", "Dermatological", "Conditions"], "created_at": "2018-09-10 15:54:00"}
{"text": ["Lilly", "(LLY)", "Hits", "52-Week", "High,", "Can", "the", "Run", "Continue?"], "created_at": "2018-09-10 14:48:24"}
{"text": ["Lilly", "(LLY)", "Hits", "52-Week", "High,", "Can", "the", "Run", "Continue?"], "created_at": "2018-09-10 14:48:24"}
{"text": ["Glaxo&apos;s", "Nucala", "Suffers", "Regulatory", "Setback,", "Gets", "CRL", "for", "COPD"], "created_at": "2018-09-10 14:19:02"}
{"text": ["Lilly", "(LLY)", "Hits", "52-Week", "High,", "Can", "the", "Run", "Continue?"], "created_at": "2018-09-10 13:15:01"}
{"text": ["Lilly", "Announces", "Initiation", "of", "IXORA-R", "Head-to-Head", "Trial", "Comparing", "Taltz\u00ae", "and", "Tremfya\u00ae", "in", "Patients", "with", "Moderate-to-Severe", "Plaque", "Psoriasis"], "created_at": "2018-09-10 13:00:00"}
